Amber photobiomodulation versus tranexamic acid for the treatment of melasma: protocol for a double-blind, randomised controlled trial

INTRODUCTION: Photobiomodulation (PBM) has been suggested as an alternative treatment for melasma. In vitro studies have shown PBM with amber light inhibits the tyrosinase enzyme, induces autophagy and reduces the melanin content, but randomised controlled clinical trials are still needed. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Galache, Thais Rodrigues, Galache, Marcelo, Sena, Michelle Mota, Pavani, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364183/
https://www.ncbi.nlm.nih.gov/pubmed/37479524
http://dx.doi.org/10.1136/bmjopen-2023-073568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364183/
https://www.ncbi.nlm.nih.gov/pubmed/37479524
http://dx.doi.org/10.1136/bmjopen-2023-073568

Ejemplares similares